Stay updated on Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page.
Latest updates to the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.3%
- Check26 days agoChange DetectedThe website has been updated from version v2.12.2 to v2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check41 days agoChange DetectedNo new additions were noted, but several options for downloading data in various formats and selecting specific fields have been removed from the website.SummaryDifference13%
- Check48 days agoChange DetectedSeveral key government health and research websites have been removed from the monitored list, indicating a potential shift in focus or resources.SummaryDifference0.7%
- Check55 days agoChange DetectedThe website has been updated to version 2.12.2, adding several new links to health-related resources and enhancing the data download options with various file formats and fields.SummaryDifference17%
- Check62 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.3%
Stay in the know with updates to Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page.